Australian Medical Association
The TGA has advised that pharmaceutical company Novo Nordisk has resolved the shortage of GlucaGen HypoKit
The shortage of GlucaGen HypoKit has now been resolved by pharmaceutical company Novo Nordisk.
The update was published on the TGA's Medicine Shortages Reports Database.
The supply of GlucaGen Hypokit will be monitored closely.
/AMA/AusMed News. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).
